<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome&amp;fc=20230708114047&amp;ff=20241113231330&amp;v=2.18.0.post9+e462414&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;utm_campaign=pubmed-2
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome&amp;fc=20230708114047&amp;ff=20241113231330&amp;v=2.18.0.post9+e462414&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;utm_campaign=pubmed-2" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Thu, 14 Nov 2024 04:13:31 +0000</lastbuilddate>
<pubDate>Wed, 13 Nov 2024 06:00:00 -0500</pubDate>
<ttl>120</ttl>
<item>
<title>Clonal Hematopoiesis of Indeterminate Potential</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39535811/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241113231330&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2024 Nov 13. doi: 10.1001/jamacardio.2024.3773. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39535811/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241113231330&v=2.18.0.post9+e462414">39535811</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2024.3773>10.1001/jamacardio.2024.3773</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39535811</guid>
<pubDate>Wed, 13 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Peter Libby</dc:creator>
<dc:creator>Ohad Oren</dc:creator>
<dc:creator>Aeron M Small</dc:creator>
<dc:date>2024-11-13</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Clonal Hematopoiesis of Indeterminate Potential</dc:title>
<dc:identifier>pmid:39535811</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2024.3773</dc:identifier>
</item>
<item>
<title>Bidirectional Risk Modulator and Modifier Variant of Dilated and Hypertrophic Cardiomyopathy in BAG3</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39535783/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241113231330&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS AND RELEVANCE: BAG3 C151R was identified as a bidirectional modulator of risk along the DCM-HCM spectrum, as well as an important genetic modifier variant in TTN-mediated DCM. This work expands on the understanding of the etiology and penetrance of DCM, suggesting that BAG3 C151R is an important genetic modifier variant contributing to the variable expressivity of DCM, warranting further exploration of its mechanisms and of genetic modifiers in DCM more broadly.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2024 Nov 13. doi: 10.1001/jamacardio.2024.3547. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">IMPORTANCE: The genetic factors that modulate the reduced penetrance and variable expressivity of heritable dilated cardiomyopathy (DCM) are largely unknown. BAG3 genetic variants have been implicated in both DCM and hypertrophic cardiomyopathy (HCM), nominating BAG3 as a gene that harbors potential modifier variants in DCM.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: To interrogate the clinical traits and diseases associated with BAG3 coding variation.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DESIGN, SETTING, AND PARTICIPANTS: This was a cross-sectional study in the Penn Medicine BioBank (PMBB) enrolling patients of the University of Pennsylvania Health System's clinical practice sites from 2014 to 2023. Whole-exome sequencing (WES) was linked to electronic health record (EHR) data to associate BAG3 coding variants with EHR phenotypes. This was a health care population-based study including individuals of European and African genetic ancestry in the PMBB with WES linked to EHR phenotypes, with replication studies in BioVU, UK Biobank, MyCode, and DCM Precision Medicine Study.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">EXPOSURES: Carrier status for BAG3 coding variants.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">MAIN OUTCOMES AND MEASURES: Association of BAG3 coding variation with clinical diagnoses, echocardiographic traits, and longitudinal outcomes.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: In PMBB (n = 43 731; median [IQR] age, 65 [50-76] years; 21 907 female [50.1%]), among 30 324 European and 11 198 African individuals, the common C151R variant was associated with decreased risk for DCM (odds ratio [OR], 0.85; 95% CI, 0.78-0.92) and simultaneous increased risk for HCM (OR, 1.59; 95% CI, 1.25-2.02), which was confirmed in the replication cohorts. C151R carriers exhibited improved longitudinal outcomes compared with noncarriers as assessed by age at death (hazard ratio [HR], 0.85; 95% CI, 0.74-0.96; median [IQR] age, 71.8 [63.1-80.7] in carriers and 70.3 [61.6-79.2] in noncarriers) and heart transplant (HR, 0.81; 95% CI, 0.66-0.99; median [IQR] age, 56.7 [46.1-63.1] in carriers and 55.6 [45.2-62.9] in noncarriers). C151R was associated with reduced risk of DCM (OR, 0.42; 95% CI, 0.24-0.74) and heart failure (OR, 0.27; 95% CI, 0.14-0.50) among individuals harboring truncating TTN variants in exons with high cardiac expression (n = 358).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS AND RELEVANCE: BAG3 C151R was identified as a bidirectional modulator of risk along the DCM-HCM spectrum, as well as an important genetic modifier variant in TTN-mediated DCM. This work expands on the understanding of the etiology and penetrance of DCM, suggesting that BAG3 C151R is an important genetic modifier variant contributing to the variable expressivity of DCM, warranting further exploration of its mechanisms and of genetic modifiers in DCM more broadly.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39535783/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241113231330&v=2.18.0.post9+e462414">39535783</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2024.3547>10.1001/jamacardio.2024.3547</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39535783</guid>
<pubDate>Wed, 13 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Joseph Park</dc:creator>
<dc:creator>Michael G Levin</dc:creator>
<dc:creator>David Zhang</dc:creator>
<dc:creator>Nosheen Reza</dc:creator>
<dc:creator>Jonathan O Mead</dc:creator>
<dc:creator>Eric D Carruth</dc:creator>
<dc:creator>Melissa A Kelly</dc:creator>
<dc:creator>Alex Winters</dc:creator>
<dc:creator>Colleen M Kripke</dc:creator>
<dc:creator>Renae L Judy</dc:creator>
<dc:creator>Scott M Damrauer</dc:creator>
<dc:creator>Anjali T Owens</dc:creator>
<dc:creator>Lisa Bastarache</dc:creator>
<dc:creator>Anurag Verma</dc:creator>
<dc:creator>Daniel D Kinnamon</dc:creator>
<dc:creator>Ray E Hershberger</dc:creator>
<dc:creator>Marylyn D Ritchie</dc:creator>
<dc:creator>Daniel J Rader</dc:creator>
<dc:date>2024-11-13</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Bidirectional Risk Modulator and Modifier Variant of Dilated and Hypertrophic Cardiomyopathy in BAG3</dc:title>
<dc:identifier>pmid:39535783</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2024.3547</dc:identifier>
</item>
<item>
<title>Emergency Medical Service Agency Cardiac Arrest Practices-Reply</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39535779/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241113231330&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2024 Nov 13. doi: 10.1001/jamacardio.2024.3954. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39535779/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241113231330&v=2.18.0.post9+e462414">39535779</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2024.3954>10.1001/jamacardio.2024.3954</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39535779</guid>
<pubDate>Wed, 13 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Saket Girotra</dc:creator>
<dc:creator>Paul S Chan</dc:creator>
<dc:date>2024-11-13</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Emergency Medical Service Agency Cardiac Arrest Practices-Reply</dc:title>
<dc:identifier>pmid:39535779</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2024.3954</dc:identifier>
</item>
<item>
<title>Correction to: Routine application of cardiac magnetic resonance imaging in patients with suspected myocarditis from immune checkpoint inhibitor therapy</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39535751/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241113231330&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Nov 13:ehae807. doi: 10.1093/eurheartj/ehae807. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39535751/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241113231330&v=2.18.0.post9+e462414">39535751</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae807>10.1093/eurheartj/ehae807</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39535751</guid>
<pubDate>Wed, 13 Nov 2024 06:00:00 -0500</pubDate>
<dc:date>2024-11-13</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Correction to: Routine application of cardiac magnetic resonance imaging in patients with suspected myocarditis from immune checkpoint inhibitor therapy</dc:title>
<dc:identifier>pmid:39535751</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae807</dc:identifier>
</item>
<item>
<title>Emergency Medical Service Agency Cardiac Arrest Practices</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39535750/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241113231330&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2024 Nov 13. doi: 10.1001/jamacardio.2024.3957. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39535750/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241113231330&v=2.18.0.post9+e462414">39535750</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2024.3957>10.1001/jamacardio.2024.3957</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39535750</guid>
<pubDate>Wed, 13 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Henry E Wang</dc:creator>
<dc:date>2024-11-13</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Emergency Medical Service Agency Cardiac Arrest Practices</dc:title>
<dc:identifier>pmid:39535750</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2024.3957</dc:identifier>
</item>
<item>
<title>JAMA Cardiology</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39535562/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241113231330&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2024 Nov 1;9(11):954. doi: 10.1001/jamacardio.2023.3683.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39535562/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241113231330&v=2.18.0.post9+e462414">39535562</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2023.3683>10.1001/jamacardio.2023.3683</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39535562</guid>
<pubDate>Wed, 13 Nov 2024 06:00:00 -0500</pubDate>
<dc:date>2024-11-13</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>JAMA Cardiology</dc:title>
<dc:identifier>pmid:39535562</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2023.3683</dc:identifier>
</item>
<item>
<title>Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement From the American Heart Association</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39534969/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241113231330&amp;v=2.18.0.post9+e462414
      <description>Kawasaki disease (KD), an acute self-limited febrile illness that primarily affects children &lt;5 years old, is the leading cause of acquired heart disease in developed countries, with the potential of leading to coronary artery dilation and coronary artery aneurysms in 25% of untreated patients. This update summarizes relevant clinical data published since the 2017 American Heart Association scientific statement on KD related to diagnosis, cardiac imaging in acute KD treatment, and long-term...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Nov 13. doi: 10.1161/CIR.0000000000001295. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Kawasaki disease (KD), an acute self-limited febrile illness that primarily affects children &lt;5 years old, is the leading cause of acquired heart disease in developed countries, with the potential of leading to coronary artery dilation and coronary artery aneurysms in 25% of untreated patients. This update summarizes relevant clinical data published since the 2017 American Heart Association scientific statement on KD related to diagnosis, cardiac imaging in acute KD treatment, and long-term management. Criteria defining North American patients at high risk for developing coronary artery aneurysms who may benefit from more intensive initial treatment have been published. Advances in cardiovascular imaging have improved the ability to identify coronary artery stenosis in patients with KD, yet knowledge gaps remain regarding optimal frequency of serial imaging and the best imaging modality to identify those at risk for inducible myocardial ischemia. Recent data have advanced the understanding of safety and dosing for several anti-inflammatory therapies in KD. New anticoagulation medication, myocardial infarction management, transition of health care for patients with KD, and future directions in research are discussed.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39534969/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241113231330&v=2.18.0.post9+e462414">39534969</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001295>10.1161/CIR.0000000000001295</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39534969</guid>
<pubDate>Wed, 13 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Pei-Ni Jone</dc:creator>
<dc:creator>Adriana Tremoulet</dc:creator>
<dc:creator>Nadine Choueiter</dc:creator>
<dc:creator>Samuel R Dominguez</dc:creator>
<dc:creator>Ashraf S Harahsheh</dc:creator>
<dc:creator>Yoshihide Mitani</dc:creator>
<dc:creator>Meghan Zimmerman</dc:creator>
<dc:creator>Ming-Tai Lin</dc:creator>
<dc:creator>Kevin G Friedman</dc:creator>
<dc:creator>American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Lifelong Congenital Heart Disease and Heart Health in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Radiology and Intervention; and Council on Clinical Cardiology</dc:creator>
<dc:date>2024-11-13</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement From the American Heart Association</dc:title>
<dc:identifier>pmid:39534969</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001295</dc:identifier>
</item>
<item>
<title>The MSc in clinical trials at the University of Oxford: training the next generation of clinical trialists</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39533844/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241113231330&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Nov 13:ehae669. doi: 10.1093/eurheartj/ehae669. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39533844/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241113231330&v=2.18.0.post9+e462414">39533844</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae669>10.1093/eurheartj/ehae669</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39533844</guid>
<pubDate>Wed, 13 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Felix Ehret</dc:creator>
<dc:creator>Tarek Bekfani</dc:creator>
<dc:creator>Manan Pareek</dc:creator>
<dc:date>2024-11-13</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>The MSc in clinical trials at the University of Oxford: training the next generation of clinical trialists</dc:title>
<dc:identifier>pmid:39533844</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae669</dc:identifier>
</item>
<item>
<title>Spatiotemporal modeling of molecular holograms</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39532097/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241113231330&amp;v=2.18.0.post9+e462414
      <description>Quantifying spatiotemporal dynamics during embryogenesis is crucial for understanding congenital diseases. We developed Spateo (https://github.com/aristoteo/spateo-release), a 3D spatiotemporal modeling framework, and applied it to a 3D mouse embryogenesis atlas at E9.5 and E11.5, capturing eight million cells. Spateo enables scalable, partial, non-rigid alignment, multi-slice refinement, and mesh correction to create molecular holograms of whole embryos. It introduces digitization methods to...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Nov 11:S0092-8674(24)01159-0. doi: 10.1016/j.cell.2024.10.011. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Quantifying spatiotemporal dynamics during embryogenesis is crucial for understanding congenital diseases. We developed Spateo (https://github.com/aristoteo/spateo-release), a 3D spatiotemporal modeling framework, and applied it to a 3D mouse embryogenesis atlas at E9.5 and E11.5, capturing eight million cells. Spateo enables scalable, partial, non-rigid alignment, multi-slice refinement, and mesh correction to create molecular holograms of whole embryos. It introduces digitization methods to uncover multi-level biology from subcellular to whole organ, identifying expression gradients along orthogonal axes of emergent 3D structures, e.g., secondary organizers such as midbrain-hindbrain boundary (MHB). Spateo further jointly models intercellular and intracellular interaction to dissect signaling landscapes in 3D structures, including the zona limitans intrathalamica (ZLI). Lastly, Spateo introduces "morphometric vector fields" of cell migration and integrates spatial differential geometry to unveil molecular programs underlying asymmetrical murine heart organogenesis and others, bridging macroscopic changes with molecular dynamics. Thus, Spateo enables the study of organ ecology at a molecular level in 3D space over time.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39532097/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241113231330&v=2.18.0.post9+e462414">39532097</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.10.011>10.1016/j.cell.2024.10.011</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39532097</guid>
<pubDate>Tue, 12 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Xiaojie Qiu</dc:creator>
<dc:creator>Daniel Y Zhu</dc:creator>
<dc:creator>Yifan Lu</dc:creator>
<dc:creator>Jiajun Yao</dc:creator>
<dc:creator>Zehua Jing</dc:creator>
<dc:creator>Kyung Hoi Min</dc:creator>
<dc:creator>Mengnan Cheng</dc:creator>
<dc:creator>Hailin Pan</dc:creator>
<dc:creator>Lulu Zuo</dc:creator>
<dc:creator>Samuel King</dc:creator>
<dc:creator>Qi Fang</dc:creator>
<dc:creator>Huiwen Zheng</dc:creator>
<dc:creator>Mingyue Wang</dc:creator>
<dc:creator>Shuai Wang</dc:creator>
<dc:creator>Qingquan Zhang</dc:creator>
<dc:creator>Sichao Yu</dc:creator>
<dc:creator>Sha Liao</dc:creator>
<dc:creator>Chao Liu</dc:creator>
<dc:creator>Xinchao Wu</dc:creator>
<dc:creator>Yiwei Lai</dc:creator>
<dc:creator>Shijie Hao</dc:creator>
<dc:creator>Zhewei Zhang</dc:creator>
<dc:creator>Liang Wu</dc:creator>
<dc:creator>Yong Zhang</dc:creator>
<dc:creator>Mei Li</dc:creator>
<dc:creator>Zhencheng Tu</dc:creator>
<dc:creator>Jinpei Lin</dc:creator>
<dc:creator>Zhuoxuan Yang</dc:creator>
<dc:creator>Yuxiang Li</dc:creator>
<dc:creator>Ying Gu</dc:creator>
<dc:creator>David Ellison</dc:creator>
<dc:creator>Ao Chen</dc:creator>
<dc:creator>Longqi Liu</dc:creator>
<dc:creator>Jonathan S Weissman</dc:creator>
<dc:creator>Jiayi Ma</dc:creator>
<dc:creator>Xun Xu</dc:creator>
<dc:creator>Shiping Liu</dc:creator>
<dc:creator>Yinqi Bai</dc:creator>
<dc:date>2024-11-12</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Spatiotemporal modeling of molecular holograms</dc:title>
<dc:identifier>pmid:39532097</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.10.011</dc:identifier>
</item>
<item>
<title>Differential contributions of fetal mononuclear phagocytes to Zika virus neuroinvasion versus neuroprotection during congenital infection</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39532096/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241113231330&amp;v=2.18.0.post9+e462414
      <description>Fetal immune cell functions during congenital infections are poorly understood. Zika virus (ZIKV) can vertically transmit from mother to fetus, causing nervous system infection and congenital ZIKV syndrome (CZS). We identified differential functional roles for fetal monocyte/macrophage cell types and microglia in ZIKV dissemination versus clearance using mouse models. Trafficking of ZIKV-infected primitive macrophages from the yolk sac allowed initial fetal virus inoculation, while recruited...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Nov 6:S0092-8674(24)01210-8. doi: 10.1016/j.cell.2024.10.028. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Fetal immune cell functions during congenital infections are poorly understood. Zika virus (ZIKV) can vertically transmit from mother to fetus, causing nervous system infection and congenital ZIKV syndrome (CZS). We identified differential functional roles for fetal monocyte/macrophage cell types and microglia in ZIKV dissemination versus clearance using mouse models. Trafficking of ZIKV-infected primitive macrophages from the yolk sac allowed initial fetal virus inoculation, while recruited monocytes promoted non-productive neuroinflammation. Conversely, brain-resident differentiated microglia were protective, limiting infection and neuronal death. Single-cell RNA sequencing identified transcriptional profiles linked to the protective versus detrimental contributions of mononuclear phagocyte subsets. In human brain organoids, microglia also promoted neuroprotective transcriptional changes and infection clearance. Thus, microglia are protective before birth, contrasting with the disease-enhancing roles of primitive macrophages and monocytes. Differential modulation of myeloid cell phenotypes by genetically divergent ZIKVs underscores the potential of immune cells to regulate diverse outcomes during fetal infections.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39532096/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241113231330&v=2.18.0.post9+e462414">39532096</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.10.028>10.1016/j.cell.2024.10.028</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39532096</guid>
<pubDate>Tue, 12 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Muhammad Abdelbasset</dc:creator>
<dc:creator>Wilfried A A Saron</dc:creator>
<dc:creator>Dongliang Ma</dc:creator>
<dc:creator>Abhay P S Rathore</dc:creator>
<dc:creator>Tatsuya Kozaki</dc:creator>
<dc:creator>Chengwei Zhong</dc:creator>
<dc:creator>Chinmay Kumar Mantri</dc:creator>
<dc:creator>Yingrou Tan</dc:creator>
<dc:creator>Chi-Ching Tung</dc:creator>
<dc:creator>Hong Liang Tey</dc:creator>
<dc:creator>Justin Jang Hann Chu</dc:creator>
<dc:creator>Jinmiao Chen</dc:creator>
<dc:creator>Lai Guan Ng</dc:creator>
<dc:creator>Hongyan Wang</dc:creator>
<dc:creator>Florent Ginhoux</dc:creator>
<dc:creator>Ashley L St John</dc:creator>
<dc:date>2024-11-12</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Differential contributions of fetal mononuclear phagocytes to Zika virus neuroinvasion versus neuroprotection during congenital infection</dc:title>
<dc:identifier>pmid:39532096</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.10.028</dc:identifier>
</item>
<item>
<title>Decreased lipidated ApoE-receptor interactions confer protection against pathogenicity of ApoE and its lipid cargoes in lysosomes</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39532095/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241113231330&amp;v=2.18.0.post9+e462414
      <description>While apolipoprotein E (APOE) is the strongest genetic modifier for late-onset Alzheimer's disease (LOAD), the molecular mechanisms underlying isoform-dependent risk and the relevance of ApoE-associated lipids remain elusive. Here, we report that impaired low-density lipoprotein (LDL) receptor (LDLR) binding of lipidated ApoE2 (lipApoE2) avoids LDLR recycling defects observed with lipApoE3/E4 and decreases the uptake of cholesteryl esters (CEs), which are lipids linked to neurodegeneration. In...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Nov 7:S0092-8674(24)01209-1. doi: 10.1016/j.cell.2024.10.027. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">While apolipoprotein E (APOE) is the strongest genetic modifier for late-onset Alzheimer's disease (LOAD), the molecular mechanisms underlying isoform-dependent risk and the relevance of ApoE-associated lipids remain elusive. Here, we report that impaired low-density lipoprotein (LDL) receptor (LDLR) binding of lipidated ApoE2 (lipApoE2) avoids LDLR recycling defects observed with lipApoE3/E4 and decreases the uptake of cholesteryl esters (CEs), which are lipids linked to neurodegeneration. In human neurons, the addition of ApoE carrying polyunsaturated fatty acids (PUFAs)-CE revealed an allelic series (ApoE4 >; ApoE3 >; ApoE2) associated with lipofuscinosis, an age-related lysosomal pathology resulting from lipid peroxidation. Lipofuscin increased lysosomal accumulation of tau fibrils and was elevated in the APOE4 mouse brain with exacerbation by tau pathology. Intrahippocampal injection of PUFA-CE-lipApoE4 was sufficient to induce lipofuscinosis in wild-type mice. Finally, the protective Christchurch mutation also reduced LDLR binding and phenocopied ApoE2. Collectively, our data strongly suggest decreased lipApoE-LDLR interactions minimize LOAD risk by reducing the deleterious effects of endolysosomal targeting of ApoE and associated pathogenic lipids.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39532095/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241113231330&v=2.18.0.post9+e462414">39532095</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.10.027>10.1016/j.cell.2024.10.027</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39532095</guid>
<pubDate>Tue, 12 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Jing L Guo</dc:creator>
<dc:creator>Dylan Braun</dc:creator>
<dc:creator>Gabriel A Fitzgerald</dc:creator>
<dc:creator>Yun-Ting Hsieh</dc:creator>
<dc:creator>Lionel Rougé</dc:creator>
<dc:creator>Alexandra Litvinchuk</dc:creator>
<dc:creator>Micah Steffek</dc:creator>
<dc:creator>Nicholas E Propson</dc:creator>
<dc:creator>Catherine M Heffner</dc:creator>
<dc:creator>Claire Discenza</dc:creator>
<dc:creator>Suk Ji Han</dc:creator>
<dc:creator>Anil Rana</dc:creator>
<dc:creator>Lukas L Skuja</dc:creator>
<dc:creator>Bi Qi Lin</dc:creator>
<dc:creator>Elizabeth W Sun</dc:creator>
<dc:creator>Sonnet S Davis</dc:creator>
<dc:creator>Srijana Balasundar</dc:creator>
<dc:creator>Isabel Becerra</dc:creator>
<dc:creator>Jason C Dugas</dc:creator>
<dc:creator>Connie Ha</dc:creator>
<dc:creator>Jennifer Hsiao-Nakamoto</dc:creator>
<dc:creator>Fen Huang</dc:creator>
<dc:creator>Shourya Jain</dc:creator>
<dc:creator>Jennifer E Kung</dc:creator>
<dc:creator>Nicholas P D Liau</dc:creator>
<dc:creator>Cathal S Mahon</dc:creator>
<dc:creator>Hoang N Nguyen</dc:creator>
<dc:creator>Nathan Nguyen</dc:creator>
<dc:creator>Madhuja Samaddar</dc:creator>
<dc:creator>Yajuan Shi</dc:creator>
<dc:creator>David Tatarakis</dc:creator>
<dc:creator>Yuxi Tian</dc:creator>
<dc:creator>Yuda Zhu</dc:creator>
<dc:creator>Jung H Suh</dc:creator>
<dc:creator>Thomas Sandmann</dc:creator>
<dc:creator>Meredith E K Calvert</dc:creator>
<dc:creator>Annie Arguello</dc:creator>
<dc:creator>Lesley A Kane</dc:creator>
<dc:creator>Joseph W Lewcock</dc:creator>
<dc:creator>David M Holtzman</dc:creator>
<dc:creator>Christopher M Koth</dc:creator>
<dc:creator>Gilbert Di Paolo</dc:creator>
<dc:date>2024-11-12</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Decreased lipidated ApoE-receptor interactions confer protection against pathogenicity of ApoE and its lipid cargoes in lysosomes</dc:title>
<dc:identifier>pmid:39532095</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.10.027</dc:identifier>
</item>
<item>
<title>Transcriptome-scale RNA-targeting CRISPR screens reveal essential lncRNAs in human cells</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39532094/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241113231330&amp;v=2.18.0.post9+e462414
      <description>Mammalian genomes host a diverse array of RNA that includes protein-coding and noncoding transcripts. However, the functional roles of most long noncoding RNAs (lncRNAs) remain elusive. Using RNA-targeting CRISPR-Cas13 screens, we probed how the loss of ∼6,200 lncRNAs impacts cell fitness across five human cell lines and identified 778 lncRNAs with context-specific or broad essentiality. We confirm their essentiality with individual perturbations and find that the majority of essential lncRNAs...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Nov 11:S0092-8674(24)01203-0. doi: 10.1016/j.cell.2024.10.021. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Mammalian genomes host a diverse array of RNA that includes protein-coding and noncoding transcripts. However, the functional roles of most long noncoding RNAs (lncRNAs) remain elusive. Using RNA-targeting CRISPR-Cas13 screens, we probed how the loss of ∼6,200 lncRNAs impacts cell fitness across five human cell lines and identified 778 lncRNAs with context-specific or broad essentiality. We confirm their essentiality with individual perturbations and find that the majority of essential lncRNAs operate independently of their nearest protein-coding genes. Using transcriptome profiling in single cells, we discover that the loss of essential lncRNAs impairs cell-cycle progression and drives apoptosis. Many essential lncRNAs demonstrate dynamic expression across tissues during development. Using ∼9,000 primary tumors, we pinpoint those lncRNAs whose expression in tumors correlates with survival, yielding new biomarkers and potential therapeutic targets. This transcriptome-wide survey of functional lncRNAs advances our understanding of noncoding transcripts and demonstrates the potential of transcriptome-scale noncoding screens with Cas13.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39532094/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241113231330&v=2.18.0.post9+e462414">39532094</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.10.021>10.1016/j.cell.2024.10.021</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39532094</guid>
<pubDate>Tue, 12 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Wen-Wei Liang</dc:creator>
<dc:creator>Simon Müller</dc:creator>
<dc:creator>Sydney K Hart</dc:creator>
<dc:creator>Hans-Hermann Wessels</dc:creator>
<dc:creator>Alejandro Méndez-Mancilla</dc:creator>
<dc:creator>Akash Sookdeo</dc:creator>
<dc:creator>Olivia Choi</dc:creator>
<dc:creator>Christina M Caragine</dc:creator>
<dc:creator>Alba Corman</dc:creator>
<dc:creator>Lu Lu</dc:creator>
<dc:creator>Olena Kolumba</dc:creator>
<dc:creator>Breanna Williams</dc:creator>
<dc:creator>Neville E Sanjana</dc:creator>
<dc:date>2024-11-12</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Transcriptome-scale RNA-targeting CRISPR screens reveal essential lncRNAs in human cells</dc:title>
<dc:identifier>pmid:39532094</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.10.021</dc:identifier>
</item>
<item>
<title>Thoracoscopic hypothermic fibrillatory arrest mitral valve replacement for severe mitral regurgitation in Marfan syndrome after Bentall procedure</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39530522/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241113231330&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Nov 12:ehae772. doi: 10.1093/eurheartj/ehae772. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39530522/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241113231330&v=2.18.0.post9+e462414">39530522</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae772>10.1093/eurheartj/ehae772</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39530522</guid>
<pubDate>Tue, 12 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>ZhengHong Li</dc:creator>
<dc:creator>Daokang Xiang</dc:creator>
<dc:creator>Kui Hu</dc:creator>
<dc:date>2024-11-12</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Thoracoscopic hypothermic fibrillatory arrest mitral valve replacement for severe mitral regurgitation in Marfan syndrome after Bentall procedure</dc:title>
<dc:identifier>pmid:39530522</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae772</dc:identifier>
</item>
<item>
<title>2024 American Heart Association and American Academy of Pediatrics Focused Update on Special Circumstances: Resuscitation Following Drowning: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39530204/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241113231330&amp;v=2.18.0.post9+e462414
      <description>Drowning is the third leading cause of death from unintentional injury worldwide, accounting for 7% of all injury-related deaths. The World Health Organization estimates that there are ≈236 000 deaths due to drowning worldwide each year. Significant efforts have focused on creating systems to prevent drowning, but an average of 4000 fatal and 8000 nonfatal drownings still occur annually in the United States-likely an underestimate. Drowning generally progresses from initial respiratory arrest...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Nov 12. doi: 10.1161/CIR.0000000000001274. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Drowning is the third leading cause of death from unintentional injury worldwide, accounting for 7% of all injury-related deaths. The World Health Organization estimates that there are ≈236 000 deaths due to drowning worldwide each year. Significant efforts have focused on creating systems to prevent drowning, but an average of 4000 fatal and 8000 nonfatal drownings still occur annually in the United States-likely an underestimate. Drowning generally progresses from initial respiratory arrest due to submersion-related hypoxia to cardiac arrest; thus, it can be challenging to distinguish respiratory arrest from cardiac arrest because pulses are difficult to accurately palpate within the recommended 10-second window. Therefore, resuscitation from cardiac arrest attributable to this specific circumstance must focus on restoring breathing as much as it does circulation. Resuscitation from drowning may begin with in-water rescue breathing when safely provided by rescuers trained in the technique and should continue with chest compressions, in keeping with basic life support guidelines, once the drowned individual and the rescuer are in a safe environment (eg, dry land, a boat). This focused update incorporates systematic reviews from 2021 to 2023 performed by the International Liaison Committee on Resuscitation related to the resuscitation of drowning. These clinical guidelines are the product of a committee of experts representing the American Heart Association and the American Academy of Pediatrics. The writing group reviewed the recent International Liaison Committee on Resuscitation systematic reviews, including updated literature searches, prior guidelines related to resuscitation from cardiac arrest following drowning, and other drowning-related publications from the American Heart Association and American Academy of Pediatrics. The writing group used these reviews to update its recommendations aimed at resuscitation of cardiac arrest following drowning in adults and children.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39530204/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241113231330&v=2.18.0.post9+e462414">39530204</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001274>10.1161/CIR.0000000000001274</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39530204</guid>
<pubDate>Tue, 12 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Cameron Dezfulian</dc:creator>
<dc:creator>Tracy E McCallin</dc:creator>
<dc:creator>Joost Bierens</dc:creator>
<dc:creator>Cody L Dunne</dc:creator>
<dc:creator>Ahamed H Idris</dc:creator>
<dc:creator>Andrew Kiragu</dc:creator>
<dc:creator>Melissa Mahgoub</dc:creator>
<dc:creator>Rohit P Shenoi</dc:creator>
<dc:creator>David Szpilman</dc:creator>
<dc:creator>Mark Terry</dc:creator>
<dc:creator>Janice A Tijssen</dc:creator>
<dc:creator>Joshua M Tobin</dc:creator>
<dc:creator>Alexis A Topjian</dc:creator>
<dc:date>2024-11-12</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>2024 American Heart Association and American Academy of Pediatrics Focused Update on Special Circumstances: Resuscitation Following Drowning: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care</dc:title>
<dc:identifier>pmid:39530204</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001274</dc:identifier>
</item>
<item>
<title>Weekly Journal Scan: Should we treat obstructive coronary artery disease in patients undergoing transcatheter aortic valve implantation?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39529376/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241113231330&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Nov 12:ehae761. doi: 10.1093/eurheartj/ehae761. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39529376/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241113231330&v=2.18.0.post9+e462414">39529376</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae761>10.1093/eurheartj/ehae761</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39529376</guid>
<pubDate>Tue, 12 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Rocco Vergallo</dc:creator>
<dc:creator>Daniela Pedicino</dc:creator>
<dc:date>2024-11-12</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Weekly Journal Scan: Should we treat obstructive coronary artery disease in patients undergoing transcatheter aortic valve implantation?</dc:title>
<dc:identifier>pmid:39529376</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae761</dc:identifier>
</item>
<item>
<title>Pregnancy, aortic events, and neonatal and maternal outcomes</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39528388/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241113231330&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: The association between pregnancy and aortic events was established in this study. The results revealed that women are at risk of aortic events from the gestational period to 1-year postpartum. Maternal mortality was significantly higher in pregnancies with aortic events than in those without. A higher late mortality and more complications were noted for neonatal deliveries with maternal aortic events. Early awareness of pregnant women at risk of aortic events-especially those with...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Nov 12:ehae757. doi: 10.1093/eurheartj/ehae757. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: This study aimed to evaluate the association between pregnancy and aortic complications and determine related maternal and neonatal outcomes.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Records of pregnancies and neonatal deliveries from the Taiwan National Health Insurance Research Database from 2000 to 2020 were retrieved. The incidence rate ratio (IRR) was calculated to evaluate the risk factors for aortic events. Survival analysis was conducted to compare maternal and neonatal mortality with and without aortic events.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: A total of 4 785 266 pregnancies were identified among 2 833 271 childbearing women, and 2 852 449 delivered neonates. In the vulnerable and control periods, 57 and 20 aortic events occurred, resulting in incidence rates of 1.19 and 0.42 aortic events per 100 000 pregnancies, respectively. Pregnancy was established as a risk factor for aortic events (IRR: 2.86, P &lt; .001). The 1-year maternal mortality rate was significantly higher in pregnancies with aortic events than in those without such events (19.3% vs. 0.05%, P &lt; .001). Neonates whose mothers experienced aortic events had a higher late mortality (6.3% vs. 0.6%, P &lt; .001).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: The association between pregnancy and aortic events was established in this study. The results revealed that women are at risk of aortic events from the gestational period to 1-year postpartum. Maternal mortality was significantly higher in pregnancies with aortic events than in those without. A higher late mortality and more complications were noted for neonatal deliveries with maternal aortic events. Early awareness of pregnant women at risk of aortic events-especially those with concomitant hypertensive disorders of pregnancy, contributive family histories, or aortopathy-is crucial.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39528388/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241113231330&v=2.18.0.post9+e462414">39528388</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae757>10.1093/eurheartj/ehae757</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39528388</guid>
<pubDate>Mon, 11 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Shao-Wei Chen</dc:creator>
<dc:creator>Feng-Cheng Chang</dc:creator>
<dc:creator>Chun-Yu Chen</dc:creator>
<dc:creator>Yu-Ting Cheng</dc:creator>
<dc:creator>Fu-Chih Hsiao</dc:creator>
<dc:creator>Ying-Chang Tung</dc:creator>
<dc:creator>Chia-Pin Lin</dc:creator>
<dc:creator>Victor Chien-Chia Wu</dc:creator>
<dc:creator>Pao-Hsien Chu</dc:creator>
<dc:creator>An-Hsun Chou</dc:creator>
<dc:date>2024-11-11</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Pregnancy, aortic events, and neonatal and maternal outcomes</dc:title>
<dc:identifier>pmid:39528388</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae757</dc:identifier>
</item>
<item>
<title>Ketone Treatment in Heart Failure With Preserved Ejection Fraction: Recharging the Heart or Reducing Filling Pressures?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39527663/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241113231330&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Nov 12;150(20):1584-1587. doi: 10.1161/CIRCULATIONAHA.124.071608. Epub 2024 Nov 11.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39527663/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241113231330&v=2.18.0.post9+e462414">39527663</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.071608>10.1161/CIRCULATIONAHA.124.071608</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39527663</guid>
<pubDate>Mon, 11 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Suzanne N Voorrips</dc:creator>
<dc:creator>B Daan Westenbrink</dc:creator>
<dc:date>2024-11-11</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Ketone Treatment in Heart Failure With Preserved Ejection Fraction: Recharging the Heart or Reducing Filling Pressures?</dc:title>
<dc:identifier>pmid:39527663</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.071608</dc:identifier>
</item>
<item>
<title>Increased Nitric Oxide Availability: The Explanation for Recent Improvements in Saphenous Vein Graft Patency?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39527662/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241113231330&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Nov 12;150(20):1567-1569. doi: 10.1161/CIRCULATIONAHA.124.071157. Epub 2024 Nov 11.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39527662/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241113231330&v=2.18.0.post9+e462414">39527662</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.071157>10.1161/CIRCULATIONAHA.124.071157</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39527662</guid>
<pubDate>Mon, 11 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Mario Gaudino</dc:creator>
<dc:creator>Sigrid Sandner</dc:creator>
<dc:creator>Antonio Maria Calafiore</dc:creator>
<dc:date>2024-11-11</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Increased Nitric Oxide Availability: The Explanation for Recent Improvements in Saphenous Vein Graft Patency?</dc:title>
<dc:identifier>pmid:39527662</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.071157</dc:identifier>
</item>
<item>
<title>Letter by Xu et al Regarding Article, "Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial"</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39527661/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241113231330&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Nov 12;150(20):e444. doi: 10.1161/CIRCULATIONAHA.124.069975. Epub 2024 Nov 11.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39527661/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241113231330&v=2.18.0.post9+e462414">39527661</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.069975>10.1161/CIRCULATIONAHA.124.069975</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39527661</guid>
<pubDate>Mon, 11 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Xiaoqun Xu</dc:creator>
<dc:creator>Houyong Zhu</dc:creator>
<dc:creator>Kan Xu</dc:creator>
<dc:date>2024-11-11</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Letter by Xu et al Regarding Article, "Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial"</dc:title>
<dc:identifier>pmid:39527661</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.069975</dc:identifier>
</item>
<item>
<title>Identifying Atypical Interatrial Block</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39527660/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241113231330&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Nov 12;150(20):1645-1647. doi: 10.1161/CIRCULATIONAHA.124.071620. Epub 2024 Nov 11.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39527660/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241113231330&v=2.18.0.post9+e462414">39527660</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.071620>10.1161/CIRCULATIONAHA.124.071620</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39527660</guid>
<pubDate>Mon, 11 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Amin Meghdadi</dc:creator>
<dc:creator>Cengiz Burak</dc:creator>
<dc:creator>Adrian Baranchuk</dc:creator>
<dc:date>2024-11-11</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Identifying Atypical Interatrial Block</dc:title>
<dc:identifier>pmid:39527660</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.071620</dc:identifier>
</item>
<item>
<title>Letter by Y. Liang and B. Liang Regarding Article, "Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial"</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39527659/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241113231330&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Nov 12;150(20):e443. doi: 10.1161/CIRCULATIONAHA.124.069679. Epub 2024 Nov 11.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39527659/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241113231330&v=2.18.0.post9+e462414">39527659</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.069679>10.1161/CIRCULATIONAHA.124.069679</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39527659</guid>
<pubDate>Mon, 11 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Yi Liang</dc:creator>
<dc:creator>Bo Liang</dc:creator>
<dc:date>2024-11-11</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Letter by Y. Liang and B. Liang Regarding Article, "Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial"</dc:title>
<dc:identifier>pmid:39527659</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.069679</dc:identifier>
</item>





























</channel>
</rss>